A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...

Danish company is battling with Pfizer for US biotech as they seek edge in growing market for weight-loss drugs ...

President Trump promised to lower the cost of Ozempic. Mark Cuban says he's working from the same playbook as Cost Plus, ...

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...

Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...

Intensifying competition, pricing pressure and copycat versions of its weight-loss drugs are holding back sales at the pharma ...

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in ...

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

Pfizer Inc said on Monday it has filed a second lawsuit against drug developer Metsera , its controlling shareholder, and ...

Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...

In the Oval Office today, the president announced that he had secured a deal to dramatically slash the price of obesity drugs ...